CLU and urinary bladder carcinoma: Another phase II preoperative randomized controlled trial involving patients with bladder cancer showed EGCG-rich green tea extract significantly reduced biological markers of bladder cancer tissue, including PCNA and clusterin, which are associated with tumor proliferation, invasion, and migration (Gee et al., 2017).